Cargando…
Study of humoral and cellular immunity in vaccinated with mRNA‐1273
The new vaccines against SARS‐CoV‐2 have raised a lot of expectations about their ability to induce immunity and the duration of this. This is the case of mRNA vaccines such as Moderna's mRNA‐1273. Therefore, it is necessary to study the humoral and cellular immunity generated by these vaccines...
Autores principales: | Gutiérrez‐Bautista, Juan Francisco, López‐Nevot, Miguel Ángel, Gómez‐Vicente, Esther, Quesada, Trinidad, Marín, Eva María, Rodríguez, Ana, Rodríguez, Ana Isabel, Rodríguez‐Granger, Javier, Cobo, Fernando, Sampedro, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111507/ https://www.ncbi.nlm.nih.gov/pubmed/35196403 http://dx.doi.org/10.1111/apm.13215 |
Ejemplares similares
-
HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine
por: Gutiérrez-Bautista, Juan Francisco, et al.
Publicado: (2022) -
Cellular and humoral immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Jiménez, Moraima, et al.
Publicado: (2022) -
Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
por: Pérez-Flores, Isabel, et al.
Publicado: (2023) -
Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
por: Broseta, José Jesús, et al.
Publicado: (2021) -
Humoral response of the mRNA-1273 SARS-CoV-2 vaccine in peritoneal dialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2021)